Lamberto Andreotti

Last updated
Lamberto Andreotti
Born (1950-07-06) 6 July 1950 (age 73)
Rome, Italy
Alma mater Sapienza University of Rome (BS)
Massachusetts Institute of Technology (MS)
OccupationBusiness executive
Board member of
Parents

Lamberto Andreotti (born 6 July 1950) is an Italian businessman. He is currently executive chairman of the board of Bristol Myers Squibb. [1]

Contents

Biography

Early life

Andreotti was born in Rome, Italy, in 1950, the son of Italian Senator and President of the Council of Ministers Giulio Andreotti. He graduated from Sapienza University of Rome with a degree in engineering; he then earned a Master of Science degree from Massachusetts Institute of Technology. [2] [3] [4]

Professional roles

He worked for many pharmaceutical companies, including Farmitalia-Carlo Erba then with Pharmacia after Pharmacia acquired Farmitalia. [2]

In 1998, he joined Bristol-Myers Squibb as vice president and general manager of European Oncology and Italy. [2] He was elected to the Board of Directors in March 2009 and became CEO on 4 May 2010. [2] Prior to taking the role of CEO, he held the role of president and COO. [1] He retired from Bristol-Myers Squibb in 2015 and took on the role of executive chairman of the company's board, succeeding James M. Cornelius who was retiring from this role. [1]

He was elected to the board of DuPont in 2012. [5]

He was elected to the Board of Directors of UniCredit S.p.A. Bank on 12 May 2018.

Related Research Articles

A chief operating officer or chief operations officer (COO) is an executive who manages the personnel, resources, logistics, and daily operations of an organization. COOs are usually second-in-command immediately after the CEO, and reports directly to them and acts on their behalf in their absence.

<span class="mw-page-title-main">Bristol Myers Squibb</span> American pharmaceutical company

The Bristol-Myers Squibb Company, doing business as Bristol Myers Squibb (BMS), is an American multinational pharmaceutical company. Headquartered in Princeton, New Jersey, BMS is one of the world's largest pharmaceutical companies and consistently ranks on the Fortune 500 list of the largest U.S. corporations. For fiscal 2022, it had a total revenue of $46.2 billion.

Michael David Capellas is an American executive in the computer and telecommunication industries. Capellas served as chairman and CEO of First Data Corporation, acting CEO of Serena Software, chairman and CEO of Compaq Computer Corporation until its merger with Hewlett-Packard where he became president of the post-merger company briefly, and president and CEO of WorldCom where he led its merger with Verizon.

<span class="mw-page-title-main">Guerrino De Luca</span> Logitechs board of directors chairman

Guerrino De Luca is the chairman of Logitech's board of directors. He served as President and CEO from 1998 to 2008.

<span class="mw-page-title-main">Celgene</span> American biopharmaceutical company

Celgene Corporation is a pharmaceutical company that makes cancer and immunology drugs. Its major product is Revlimid (lenalidomide), which is used in the treatment of multiple myeloma, and also in certain anemias. The company is incorporated in Delaware, headquartered in Summit, New Jersey, and a subsidiary of Bristol Myers Squibb (BMS).

Craig T. Monaghan was the chief executive officer of Asbury Automotive Group.

John Mendlein is a biotech executive who has held leadership positions in biotech companies in Boston, San Diego and Toronto.

<span class="mw-page-title-main">Charles A. Heimbold Jr.</span>

Charles A. Heimbold Jr. is an American businessman and diplomat, who was Chairman and CEO of Bristol-Myers Squibb Company, and as U.S. Ambassador to Sweden. His son is American musician Pete Francis Heimbold, of Dispatch fame.

<span class="mw-page-title-main">Lowell McAdam</span> American businessman (born 1954)

Lowell Clayton McAdam is an American businessman. He is the former chairman and CEO of Verizon Communications, a company he joined in 2000.

Medarex was an American biopharmaceutical company based in Princeton, New Jersey, with manufacturing facilities in Bloomsbury and Annandale, New Jersey, and research facilities in Milpitas and Sunnyvale, California. In 2009, Medarex was purchased by Bristol Myers Squibb.

Fred Hassan, is a Pakistan-born American business executive who works for Warburg Pincus and was CEO of three global pharmaceutical companies.

Maggie Wilderotter is an American businessperson who is the chairwoman of DocuSign and the former chief executive officer of Frontier Communications, from November 2004 to April 2015; then executive chairman of the company until April 2016. During her tenure with Frontier, the company grew from a regional telephone company with customer revenues of less than $3 billion to a national broadband, voice and video provider with operations in 29 states and annualized revenues in excess of $10 billion.

Dean L. Howes Jr. is an American businessman in the field of sports management. He was the first commissioner of Major League Rugby which began its inaugural season in 2018.

Kosan Biosciences, Inc., was a pharmaceutical company which dealt with cancer therapeutics medications. The company was working on advancing two new classes of anticancer agents through clinical development: heat shock protein 90 (Hsp90) inhibitors and epothilones.

Peter R. Dolan is an American business executive. In 2009, he became chairman and CEO of Gemin X Pharmaceuticals after joining the board in July 2008; he was formerly the chief executive officer of Bristol-Myers Squibb before being discharged from that company in September 2006 as a result of a federal investigation into questions concerning the patent of drug Plavix.

William Robert Miller CBE (1928-2020) was a British-born businessman who was vice-chairman of Bristol-Myers Squibb until 1990. Subsequently, he has become a philanthropist and supporter of scientific, artistic, educational and ecclesiastical causes.

<span class="mw-page-title-main">Ramon Ang</span> Filipino businessman

Ramon See Ang, also known by his initials RSA, is a Filipino businessman. He is the president and chief executive officer (CEO) of Top Frontier Investment Holdings, Inc., the largest shareholder of San Miguel Corporation (SMC). He is also the president and CEO of SMC and the chairman of Cyber Bay Corporation and Eagle Cement Corporation.

<span class="mw-page-title-main">Jeremy Levin</span> American businessman

Jeremy Levin is a South African-born businessman, medical doctor and research scientist. In 2018, Levin was named as one of the most influential figures in the biopharmaceutical industry.

<span class="mw-page-title-main">John C. Martin (businessman)</span>

John Charles Martin was an American billionaire businessman, and the former executive chairman (2016–2018) and CEO (1996–2016) of the American biotechnology company Gilead Sciences. He joined Gilead Sciences in 1990 as vice president for research and development. Gilead is known for developing drugs such as Atripla and commercializing Sovaldi (sofosbuvir) for the treatment of the liver virus hepatitis C. Martin is the recipient of a number of awards, including the Biotechnology Heritage Award (2017).

Stephen Sadove is an American businessman. He is the former chairman and chief executive officer of Saks Incorporated.

References

  1. 1 2 3 Staff (February 15, 2015). "BMS CEO Andreotti to Retire; COO Named as Successor". Genetic Engineering & Biotechnology News (paper). Vol. 35, no. 4. p. 6.
  2. 1 2 3 4 "Bristol-Myers Squibb: Lamberto Andreotti". bms.com. May 2010. Retrieved June 12, 2012.
  3. Forbes
  4. "Lamberto Andreotti: Executive Profile & Biography - Businessweek". investing.businessweek.com. Archived from the original on January 18, 2013. Retrieved June 12, 2012.
  5. "Bio Lamberto Andreotti, CEO, Bristol-Myers Squibb". www2.dupont.com. April 2012. Retrieved June 12, 2012.